Literature DB >> 21555407

Nuclear transfer to eggs and oocytes.

J B Gurdon1, Ian Wilmut.   

Abstract

We review experiments in which somatic cell nuclei are transplanted singly to enucleated eggs (metaphase II) in amphibia and mammals and as multiple nuclei to the germinal vesicle of amphibian oocytes (prophase I). These experiments have shown the totipotency of some somatic cell nuclei, as well as switches in cell type and changes in gene expression. Abnormalities of nuclear transplant embryo development increase greatly as nuclei are taken from progressively more differentiated donor cells. The molecular changes that accompany the reprogramming of transplanted nuclei help to indicate the mechanisms used by eggs and oocytes to reprogram gene expression. We discuss the importance of chromosomal protein exchange, of transcription factor supply, and of chromatin access in reprogramming.

Entities:  

Mesh:

Year:  2011        PMID: 21555407      PMCID: PMC3098674          DOI: 10.1101/cshperspect.a002659

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  84 in total

1.  Abnormal gene expression in cloned mice derived from embryonic stem cell and cumulus cell nuclei.

Authors:  David Humpherys; Kevin Eggan; Hidenori Akutsu; Adam Friedman; Konrad Hochedlinger; Ryuzo Yanagimachi; Eric S Lander; Todd R Golub; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

Review 2.  Epigenetic reprogramming in mammals.

Authors:  Hugh D Morgan; Fátima Santos; Kelly Green; Wendy Dean; Wolf Reik
Journal:  Hum Mol Genet       Date:  2005-04-15       Impact factor: 6.150

3.  Epigenetic memory of an active gene state depends on histone H3.3 incorporation into chromatin in the absence of transcription.

Authors:  Ray Kit Ng; J B Gurdon
Journal:  Nat Cell Biol       Date:  2007-12-09       Impact factor: 28.824

4.  Hyperphosphorylation of nucleoplasmin facilitates Xenopus sperm decondensation at fertilization.

Authors:  G H Leno; A D Mills; A Philpott; R A Laskey
Journal:  J Biol Chem       Date:  1996-03-29       Impact factor: 5.157

5.  Viable offspring derived from fetal and adult mammalian cells.

Authors:  I Wilmut; A E Schnieke; J McWhir; A J Kind; K H Campbell
Journal:  Nature       Date:  1997-02-27       Impact factor: 49.962

6.  Nuclei of adult mammalian somatic cells are directly reprogrammed to oct-4 stem cell gene expression by amphibian oocytes.

Authors:  James A Byrne; Stina Simonsson; Patrick S Western; John B Gurdon
Journal:  Curr Biol       Date:  2003-07-15       Impact factor: 10.834

Review 7.  Active DNA demethylation and DNA repair.

Authors:  Christof Niehrs
Journal:  Differentiation       Date:  2008-10-25       Impact factor: 3.880

8.  Nuclear cloning of embryonal carcinoma cells.

Authors:  Robert H Blelloch; Konrad Hochedlinger; Yasuhiro Yamada; Cameron Brennan; Minjung Kim; Beatrice Mintz; Lynda Chin; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

9.  The first half-century of nuclear transplantation.

Authors:  J B Gurdon; J A Byrne
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-23       Impact factor: 12.779

10.  In vivo reprogramming of adult pancreatic exocrine cells to beta-cells.

Authors:  Qiao Zhou; Juliana Brown; Andrew Kanarek; Jayaraj Rajagopal; Douglas A Melton
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

View more
  32 in total

1.  Psammaplin a improves development and quality of somatic cell nuclear transfer mouse embryos.

Authors:  Anna Mallol; Josep Santaló; Elena Ibáñez
Journal:  Cell Reprogram       Date:  2014-07-28       Impact factor: 1.987

2.  Maintenance of multipotency in human dermal fibroblasts treated with Xenopus laevis egg extract requires exogenous fibroblast growth factor-2.

Authors:  Denis Kole; Sakthikumar Ambady; Raymond L Page; Tanja Dominko
Journal:  Cell Reprogram       Date:  2014-01-03       Impact factor: 1.987

Review 3.  Concise review: making and using clinically compliant pluripotent stem cell lines.

Authors:  Melissa K Carpenter; Mahendra S Rao
Journal:  Stem Cells Transl Med       Date:  2015-02-26       Impact factor: 6.940

Review 4.  Stem cell therapy: an exercise in patience and prudence.

Authors:  Huan-Ting Lin; Makoto Otsu; Hiromitsu Nakauchi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-05       Impact factor: 6.237

Review 5.  Recent advancements in cloning by somatic cell nuclear transfer.

Authors:  Atsuo Ogura; Kimiko Inoue; Teruhiko Wakayama
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-05       Impact factor: 6.237

6.  Identifying candidate oocyte reprogramming factors using cross-species global transcriptional analysis.

Authors:  Jason P Awe; James A Byrne
Journal:  Cell Reprogram       Date:  2013-03-04       Impact factor: 1.987

7.  Histone variant H3.3 is an essential maternal factor for oocyte reprogramming.

Authors:  Duancheng Wen; Laura A Banaszynski; Ying Liu; Fuqiang Geng; Kyung-Min Noh; Jenny Xiang; Olivier Elemento; Zev Rosenwaks; C David Allis; Shahin Rafii
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-05       Impact factor: 11.205

8.  Programming biological operating systems: genome design, assembly and activation.

Authors:  Daniel G Gibson
Journal:  Nat Methods       Date:  2014-05       Impact factor: 28.547

Review 9.  Recent advancements in understanding the role of epigenetics in the auditory system.

Authors:  Rahul Mittal; Nicole Bencie; George Liu; Nicolas Eshraghi; Eric Nisenbaum; Susan H Blanton; Denise Yan; Jeenu Mittal; Christine T Dinh; Juan I Young; Feng Gong; Xue Zhong Liu
Journal:  Gene       Date:  2020-07-29       Impact factor: 3.688

10.  microRNA-based cancer cell reprogramming technology.

Authors:  Shimpei Nishikawa; Hideshi Ishii; Naotsugu Haraguchi; Yoshihiro Kano; Takahito Fukusumi; Katsuya Ohta; Miyuki Ozaki; Dyah Laksmi Dewi; Daisuke Sakai; Taroh Satoh; Hiroaki Nagano; Yuichiro Doki; Masaki Mori
Journal:  Exp Ther Med       Date:  2012-04-23       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.